Annual EBIT
-$83.53 M
-$44.74 M-115.33%
December 31, 2023
Summary
- As of February 7, 2025, ELVN annual earnings before interest & taxes is -$83.53 million, with the most recent change of -$44.74 million (-115.33%) on December 31, 2023.
- During the last 3 years, ELVN annual EBIT has fallen by -$74.21 million (-796.43%).
- ELVN annual EBIT is now -796.43% below its all-time high of -$9.32 million, reached on December 1, 2020.
Performance
ELVN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$27.07 M
-$2.46 M-10.02%
September 30, 2024
Summary
- As of February 7, 2025, ELVN quarterly earnings before interest & taxes is -$27.07 million, with the most recent change of -$2.46 million (-10.02%) on September 30, 2024.
- Over the past year, ELVN quarterly EBIT has dropped by -$1.08 million (-4.16%).
- ELVN quarterly EBIT is now -222.43% below its all-time high of -$8.39 million, reached on December 1, 2021.
Performance
ELVN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$100.39 M
-$2.82 M-2.89%
September 30, 2024
Summary
- As of February 7, 2025, ELVN TTM earnings before interest & taxes is -$100.39 million, with the most recent change of -$2.82 million (-2.89%) on September 30, 2024.
- Over the past year, ELVN TTM EBIT has dropped by -$7.29 million (-7.83%).
- ELVN TTM EBIT is now -1095.80% below its all-time high of -$8.39 million, reached on December 1, 2021.
Performance
ELVN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ELVN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -115.3% | -4.2% | -7.8% |
| 3 y3 years | -796.4% | -64.9% | -115.7% |
| 5 y5 years | -796.4% | -64.9% | -115.7% |
ELVN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -237.3% | at low | -222.4% | at low | -1095.8% | at low |
| 5 y | 5-year | -796.4% | at low | -222.4% | at low | -1095.8% | at low |
| alltime | all time | -796.4% | at low | -222.4% | at low | -1095.8% | at low |
Enliven Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$27.07 M(+10.0%) | -$100.39 M(+2.9%) |
| Jun 2024 | - | -$24.60 M(-5.3%) | -$97.57 M(+4.8%) |
| Mar 2024 | - | -$25.99 M(+14.3%) | -$93.10 M(+11.5%) |
| Dec 2023 | -$83.53 M(+115.3%) | -$22.73 M(-6.3%) | -$83.53 M(+17.7%) |
| Sep 2023 | - | -$24.25 M(+20.4%) | -$70.96 M(+23.1%) |
| Jun 2023 | - | -$20.13 M(+22.6%) | -$57.65 M(+23.9%) |
| Mar 2023 | - | -$16.42 M(+61.5%) | -$46.53 M(+20.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$38.79 M(+56.7%) | -$10.16 M(-7.1%) | -$38.79 M(+4.8%) |
| Sep 2022 | - | -$10.93 M(+21.3%) | -$37.02 M(+41.9%) |
| Jun 2022 | - | -$9.02 M(+3.9%) | -$26.09 M(+52.8%) |
| Mar 2022 | - | -$8.68 M(+3.4%) | -$17.07 M(+103.4%) |
| Dec 2021 | -$24.76 M(+165.7%) | - | - |
| Dec 2021 | - | -$8.39 M | -$8.39 M |
| Dec 2020 | -$9.32 M | - | - |
FAQ
- What is Enliven Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Enliven Therapeutics?
- What is Enliven Therapeutics annual EBIT year-on-year change?
- What is Enliven Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Enliven Therapeutics?
- What is Enliven Therapeutics quarterly EBIT year-on-year change?
- What is Enliven Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Enliven Therapeutics?
- What is Enliven Therapeutics TTM EBIT year-on-year change?
What is Enliven Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ELVN is -$83.53 M
What is the all time high annual EBIT for Enliven Therapeutics?
Enliven Therapeutics all-time high annual earnings before interest & taxes is -$9.32 M
What is Enliven Therapeutics annual EBIT year-on-year change?
Over the past year, ELVN annual earnings before interest & taxes has changed by -$44.74 M (-115.33%)
What is Enliven Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ELVN is -$27.07 M
What is the all time high quarterly EBIT for Enliven Therapeutics?
Enliven Therapeutics all-time high quarterly earnings before interest & taxes is -$8.39 M
What is Enliven Therapeutics quarterly EBIT year-on-year change?
Over the past year, ELVN quarterly earnings before interest & taxes has changed by -$1.08 M (-4.16%)
What is Enliven Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ELVN is -$100.39 M
What is the all time high TTM EBIT for Enliven Therapeutics?
Enliven Therapeutics all-time high TTM earnings before interest & taxes is -$8.39 M
What is Enliven Therapeutics TTM EBIT year-on-year change?
Over the past year, ELVN TTM earnings before interest & taxes has changed by -$7.29 M (-7.83%)